Researchers said unless Medicare approves coverage of DNA testing for colon cancer or prices for the procedure drop considerably it will not be a cost-effective screening tool. Medicare already covers colonoscopy, flexible sigmoidoscopy, barium enema and fecal occult blood testing, all less expensive but effective colon cancer tests.

Full Story:

Related Summaries